![]() |
||||||||
These Corporate Governance Guidelines have been adopted by the Board of Directors and reflect the Board's commitment to monitor the effectiveness of policy and decision making by the Board with a view to enhancing long-term stockholder value.
The Board shall be comprised of at least a majority of directors who qualify as independent directors under the listing standards of the New York Stock Exchange (the "NYSE").
A director is expected to spend the time and effort necessary to properly discharge his or her responsibilities. A director is expected to regularly attend and participate in meetings of the Board and of committees on which the director serves, and to review material distributed in advance for such meetings.
The Board's goals are to create long-term value for the Company's stockholders while maintaining the highest standards of ethical and lawful business conduct, and thereby to assure the vitality of the Company for its customers, employees and the other individuals and organizations that depend on the Company. The Board will monitor the performance of the Company and of the Chief Executive Officer in relation to these goals. When it is appropriate or necessary, it is the Board's responsibility to remove the Chief Executive Officer and to select his or her successor.
The Board does not require the separation of the offices of the Chairman of the Board and the Chief Executive Officer. Where the Chairman is also the Chief Executive Officer, or is otherwise not an independent director, the independent directors shall designate an independent director as the Presiding Director who shall function as described in these guidelines.
The Board believes that it should generally have no fewer than three directors to permit diversity of experience.
The Nominating and Corporate Governance Committee is responsible for identifying and recommending nominees to the Board for election by the stockholders or appointment by the Board to fill vacancies on the Board.
The Nominating and Corporate Governance Committee shall be responsible for assessing the appropriate balance of criteria required of Board members and shall consider, among other things, a nominee's experience, knowledge, skills, expertise, integrity, diversity, ability to make independent analytical inquiries, understanding of the Company's business environment and willingness to devote adequate time and effort to Board responsibilities.
A Director who is an employee of the Company is expected to resign from the Board at the same time he or she leaves employment with the Company. The Board does not believe that non-employee directors who retire or change the status they held when they became a member of the Board should necessarily leave the Board. Promptly following such event, the director must notify the Nominating and Corporate Governance Committee, which shall review the continued appropriateness of the affected director remaining on the Board under the circumstances.
It is the general policy of the Company that no director having attained the age of 70 years shall be nominated for re-election or reappointment to the Board.
In connection with each director nomination recommendation, the Nominating and Corporate Governance Committee shall consider the issue of director tenure and take steps as may be appropriate to ensure that the Board maintains openness to new ideas and a willingness to critically re-examine the status quo.
Compensation for non-employee directors should be competitive and should encourage increased ownership of the Company's stock through the payment of a portion of director compensation as equity-based compensation. The Compensation Committee will annually review the level and form of director compensation, including how such compensation relates to director compensation of companies of comparable size, industry and complexity. The only compensation a member of the Audit Committee may receive from the Company is compensation for services as a director. A director who is also an employee of the Company shall not receive additional compensation for serving as a director.
The non-management directors shall meet in executive session without management on a regularly scheduled basis, but no less than two times a year. The Presiding Director or, in such director's absence, another independent director designated by the non-management directors shall preside at such executive sessions.
The Company shall establish and disclose the method for any interested party to communicate with the Presiding Director or the non-management directors as a group.
The Nominating and Corporate Governance Committee will oversee an annual self-assessment of the Board's performance as well as the performance of each standing committee, the results of which will be discussed with the full Board and the relevant committee. The assessment should include a review of any areas in which the Board or management believes the Board or committees can make a better contribution to the Company. The Nominating and Corporate Governance Committee will utilize the results of this self-evaluation process in assessing and determining the characteristics and critical skills required of prospective candidates for election or appointment to the Board and making recommendations to the Board with respect to assignments of directors to committees.
It is management's responsibility to formalize, propose and implement strategic choices and it is the Board's responsibility to review and assess strategic direction and to evaluate strategic results.
Board members shall have access to the Company's management and to the Company's outside advisors.
The Board encourages the Chief Executive Officer to bring members of management from time to time into Board meetings to provide management insight into matters being discussed by the Board, and to bring managers with significant potential into contact with the Board.
Information and materials that are important to the Board's understanding of the agenda items to be considered at a Board meeting should, to the extent practicable, be distributed sufficiently in advance of the meeting to permit prior review by the directors.
The Company shall provide new directors with a director orientation program to familiarize such directors with, among other things, the Company's business, strategic plans, significant financial, accounting and risk management issues, compliance programs, code of business conduct and ethics, corporate governance guidelines, executive officers, internal auditors and independent auditors. Each director is expected to maintain the necessary level of expertise to discharge his or her responsibilities as a director.
There shall be at least four regularly scheduled meetings of the Board each year.
The Chairman of the Board or, if the Chairman is also the Chief Executive Officer, the Presiding Director, in consultation with the Chief Executive Officer and other directors, shall annually prepare a "Board of Directors Master Agenda." This Master Agenda shall set forth a general agenda of items to be considered by the Board at each of its scheduled meetings during the year. This does not preclude a director from recommending additional agenda items during the course of the year.
The Company shall have four standing committees: Audit, Nominating and Corporate Governance, Compensation, and Finance. The purpose and responsibilities for each of these committees shall be contained in committee charters adopted by the Board. The Board may form special committees from time to time as circumstances warrant, and determine the composition and authority of such committees.
Each of the Audit Committee, the Nominating and Corporate Governance Committee and the Compensation Committee shall be composed entirely of Independent Directors satisfying applicable statutory, regulatory and NYSE requirements for service on these committees.
The Nominating and Corporate Governance Committee shall be responsible for making recommendations to the Board with respect to the assignment of directors to committees, and shall annually review committee assignments and shall consider the rotation of the Chair and members with a view toward assessing the benefits of continuity in service against the benefits of introducing fresh viewpoints of qualified directors. The Board shall be responsible for appointing the Chair and members of the committees on at least an annual basis.
In identifying potential candidates for, and selecting, the Chief Executive Officer, the Board shall consider, among other things, a candidate's experience, understanding of the Company's business environment, leadership qualities, knowledge, skills, expertise, integrity, and reputation in the business community.
The Compensation Committee shall evaluate the performance of the Chief Executive Officer annually, before establishing his or her compensation.
The Board shall require a plan for the succession to the position of the Chief Executive Officer and other senior management positions, taking into account planning for education and management development of potential successors to such positions.
![]()
HealthSonix to Conduct Clinical Trials with ZingiberRx for Complex Regional Pain Syndrome (CRPS)
IRVINE, CA - HealthSonix, Inc. (PINKSHEETS: HSXI; FRANKFURT: H7S)- MARKET WIRE) -- 03/12/2008 - today announced that it has strong evidence that ZingiberRx Joint and Muscle Cream with ginger oil can provide pain relief for people with Complex Regional Pain Syndrome (CRPS), also referred to as Reflex Sympathetic Dystrophy (RSD).Read Press Release
HealthSonix Announces Expansion in Florida
IRVINE, CA, October 31, 2007 (MARKET WIRE) -- HealthSonix today today announced that it is has selected a prestigious medical center in Boca Raton, Florida, for the first location of its specialty Arthritis Treatment Centers of America [ATCA]. Read Press Release
Site design by Richard Munter